Your browser doesn't support javascript.
loading
Insulin and cancer: a tangled web.
Leitner, Brooks P; Siebel, Stephan; Akingbesote, Ngozi D; Zhang, Xinyi; Perry, Rachel J.
  • Leitner BP; Departments of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT, U.S.A.
  • Siebel S; Departments of Internal Medicine, Yale School of Medicine, New Haven, CT, U.S.A.
  • Akingbesote ND; Departments of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT, U.S.A.
  • Zhang X; Departments of Internal Medicine, Yale School of Medicine, New Haven, CT, U.S.A.
  • Perry RJ; Departments of Pediatrics, Yale School of Medicine, New Haven, CT, U.S.A.
Biochem J ; 479(5): 583-607, 2022 03 18.
Article en En | MEDLINE | ID: mdl-35244142
ABSTRACT
For a century, since the pioneering work of Otto Warburg, the interwoven relationship between metabolism and cancer has been appreciated. More recently, with obesity rates rising in the U.S. and worldwide, epidemiologic evidence has supported a link between obesity and cancer. A substantial body of work seeks to mechanistically unpack the association between obesity, altered metabolism, and cancer. Without question, these relationships are multifactorial and cannot be distilled to a single obesity- and metabolism-altering hormone, substrate, or factor. However, it is important to understand the hormone-specific associations between metabolism and cancer. Here, we review the links between obesity, metabolic dysregulation, insulin, and cancer, with an emphasis on current investigational metabolic adjuncts to standard-of-care cancer treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Insulina / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Insulina / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article